Logo of Papyrus Australia (ASX:PPY)Latest Papyrus Australia (ASX:PPY) News

Page 1
Page 1 of 3

Papyrus Builds TBS Sample Pipeline as Cash Runway Remains Below Six Months

Papyrus Australia has produced a second batch of TBS board samples, expanded pulp capacity in Adelaide and secured additional funding as it moves towards commercial supply. The progress comes with testing still incomplete and an estimated 4.87 months of funding available.
Victor Sage
30 Sept 2026

Papyrus reaches commercialisation milestone as going-concern warning overshadows FY26 progress

Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.
Victor Sage
22 Sept 2026

Papyrus Australia Extends TBS Trial and Secures New Loan Facility Amid Funding Push

Papyrus Australia has expanded its TBS contract for an additional sample run after mixed trial results and secured a $200,000 unsecured loan with Irwin Biotech, advancing its capital raising efforts with L39 Capital.
Victor Sage
28 Aug 2026

Papyrus Secures Additional $500,000 in Convertible Loan Facilities

Papyrus Australia has arranged a further $500,000 in unsecured loan facilities from four sophisticated investors, with conversion to unsecured convertible notes subject to shareholder approval at the 2026 AGM.
Victor Sage
14 Aug 2026

Papyrus Revises TBS Supply Milestones After Biodegradable Board Trials

Papyrus Australia updates its timeline for delivering biodegradable fibre board to TBS Mining Solutions, following trial results that require product refinements. Commercial supply is now expected from November 2026, with acceptance testing due by September.
Victor Sage
3 Aug 2026

Papyrus Australia Secures $200K Loan and Engages L39 Capital for Capital Raising

Papyrus Australia has tapped related party L39 Capital to lead a capital raise and secured an interest-bearing $200,000 loan from Irwin Biotech, with conversion into shares and options pending shareholder approval.
Victor Sage
22 July 2026

Papyrus Advances Commercial Scale Milestone with 200 Biodegradable Samples Delivered

Papyrus Australia reached a key production milestone by delivering 200 biodegradable Collar Keeper® samples to TBS Mining Solutions, confirming its manufacturing scalability. The company’s May cash flow shows a steady funding runway amid ongoing R&D and commercialisation efforts.
Victor Sage
30 June 2026

Papyrus Australia Advances Vietnam Production and Raises $325K for TBS Contract Delivery

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.
Victor Sage
29 May 2026

Papyrus Delivers Key Product Samples to TBS Within Contract Cure Period

Papyrus Australia has fulfilled a critical contract milestone by delivering 200 biodegradable Collar Keeper product samples to TBS Mining Solutions, enabling the next phase of product testing despite a slight delay.
Victor Sage
21 May 2026

Finance Wrap - Week 17 (20 Apr -> 24 Apr) 2026

Finance stocks split into two camps this week: small caps with fresh cash or growth plans surged, while several larger names fell despite solid operating updates. The clearest pattern was simple. Investors paid up for visible growth, but sold hard where profit quality, capital or market-sensitive funds came into question.
Logan Eniac
25 Apr 2026

Papyrus Australia Raises $175K Placement and Convertible Notes to Back Biodegradable Product Rollout

Papyrus Australia (ASX: PPY) has secured $175,000 through a share placement alongside convertible note conversions and related party loans, aiming to fund commercialisation and fulfil a key contract for biodegradable Collar Keeper® products.
Victor Sage
23 Apr 2026

Papyrus Australia Advances Commercial Scale-Up with New R&D Facility

Papyrus Australia has commissioned its Adelaide Rapid Prototyping & R&D Facility, marking a key step in validating its pulp technology and progressing towards commercial production. The company also released its interim financials and reported stable cash flow supporting ongoing operations.
Maxwell Dee
31 Mar 2026